18-57571493-T-C

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS1

The NM_000140.5(FECH):​c.362A>G​(p.Glu121Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000463 in 1,613,988 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00045 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00047 ( 1 hom. )

Consequence

FECH
NM_000140.5 missense

Scores

9
8
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 6.14

Publications

8 publications found
Variant links:
Genes affected
FECH (HGNC:3647): (ferrochelatase) The protein encoded by this gene is localized to the mitochondrion, where it catalyzes the insertion of the ferrous form of iron into protoporphyrin IX in the heme synthesis pathway. Mutations in this gene are associated with erythropoietic protoporphyria. Two transcript variants encoding different isoforms have been found for this gene. A pseudogene of this gene is found on chromosome 3.[provided by RefSeq, May 2010]
FECH Gene-Disease associations (from GenCC):
  • protoporphyria, erythropoietic, 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Laboratory for Molecular Medicine, ClinGen, Labcorp Genetics (formerly Invitae)
  • autosomal erythropoietic protoporphyria
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 18-57571493-T-C is Benign according to our data. Variant chr18-57571493-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 327433.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000447 (68/152098) while in subpopulation NFE AF = 0.000809 (55/67990). AF 95% confidence interval is 0.000638. There are 0 homozygotes in GnomAd4. There are 29 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FECHNM_000140.5 linkc.362A>G p.Glu121Gly missense_variant Exon 4 of 11 ENST00000262093.11 NP_000131.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FECHENST00000262093.11 linkc.362A>G p.Glu121Gly missense_variant Exon 4 of 11 1 NM_000140.5 ENSP00000262093.6

Frequencies

GnomAD3 genomes
AF:
0.000447
AC:
68
AN:
151980
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000809
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.000429
AC:
108
AN:
251474
AF XY:
0.000478
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000826
Gnomad OTH exome
AF:
0.000977
GnomAD4 exome
AF:
0.000465
AC:
680
AN:
1461890
Hom.:
1
Cov.:
31
AF XY:
0.000472
AC XY:
343
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.000201
AC:
9
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86258
European-Finnish (FIN)
AF:
0.0000374
AC:
2
AN:
53420
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5768
European-Non Finnish (NFE)
AF:
0.000553
AC:
615
AN:
1112008
Other (OTH)
AF:
0.000513
AC:
31
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
43
86
130
173
216
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000447
AC:
68
AN:
152098
Hom.:
0
Cov.:
32
AF XY:
0.000390
AC XY:
29
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.000120
AC:
5
AN:
41520
American (AMR)
AF:
0.000197
AC:
3
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4804
European-Finnish (FIN)
AF:
0.0000945
AC:
1
AN:
10582
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000809
AC:
55
AN:
67990
Other (OTH)
AF:
0.00142
AC:
3
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000576
Hom.:
0
Bravo
AF:
0.000393
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.000930
AC:
8
ExAC
AF:
0.000527
AC:
64
EpiCase
AF:
0.000818
EpiControl
AF:
0.00124

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:2
May 23, 2022
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: FECH c.362A>G (p.Glu121Gly) results in a non-conservative amino acid change located in the Ferrochelatase, N-terminal domain (IPR033659) of the encoded protein sequence. Three of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00043 in 251474 control chromosomes in the gnomAD database, including 1 homozygote. This frequency does not allow conclusions about variant significance. c.362A>G has been reported in the literature in individuals affected with Protoporphyria, Erythropoietic, 1 (example, Balwani_2013, non-primary report). These report(s) do not provide unequivocal conclusions about association of the variant with Protoporphyria, Erythropoietic, 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation (VUS, n=2; Likely Benign, n=1). Based on the evidence outlined above, the variant was classified as uncertain significance. -

Jun 02, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: literature non available -

Protoporphyria, erythropoietic, 1 Uncertain:1Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

See cases Uncertain:1
Nov 13, 2020
Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ACMG classification criteria: PP3, BS1 -

not provided Benign:1
Sep 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Pathogenic
0.17
D
BayesDel_noAF
Pathogenic
0.40
CADD
Uncertain
25
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.94
D;.;.;D;.
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.98
D;D;D;.;.
M_CAP
Uncertain
0.17
D
MetaRNN
Uncertain
0.43
T;T;T;T;T
MetaSVM
Pathogenic
0.95
D
MutationAssessor
Uncertain
2.3
M;.;.;.;.
PhyloP100
6.1
PrimateAI
Uncertain
0.52
T
PROVEAN
Pathogenic
-4.6
D;D;.;.;.
REVEL
Pathogenic
0.88
Sift
Uncertain
0.010
D;D;.;.;.
Sift4G
Uncertain
0.056
T;T;.;.;T
Polyphen
0.85
P;P;.;.;.
Vest4
0.83
MVP
0.97
MPC
1.0
ClinPred
0.17
T
GERP RS
5.8
Varity_R
0.72
Mutation Taster
=16/84
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs141813907; hg19: chr18-55238725; API